![]()  | 
![]()  | ![]()  | 
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. | 
    
     
    
    
 
    
    
    
Rosetta Inpharmatics, Inc. is a leader in the emerging field of informational genomics. Informational genomics involves acquiring and analyzing information gathered from throughout the cell, to identify a majority of the medically important drug targets and gene functions. The Company combines the power of informatics, which is the use of computers and sophisticated algorithms to store, analyze and interpret large volumes of information, and genomics, which is the study of genomes, or all of the genetic material in an organism's chromosomes, to create a proprietary platform that accelerates and enhances the drug discovery process for pharmaceutical and biotechnology companies and improves agricultural products. The Company's technology platform consists of the Rosetta Resolver system, the FlexJet DNA microarrays and coherent data sets of information generated from DNA microarrays
      | ||||||||||||||
 
        
 
  | 
    
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings | 
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI | 
| © 2025 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |